Phytochemical and biological analysis of Skullcap (Scutellaria lateriflora L.):: A medicinal plant with anxiolytic properties

被引:97
作者
Awad, R
Arnason, JT
Trudeau, V
Bergeron, C
Budzinski, JW
Foster, BC
Merali, Z
机构
[1] Univ Ottawa, Ottawa Carleton Inst Biol, Dept Biol, Ottawa, ON K1N 6N5, Canada
[2] Univ Ottawa, CAREG, Ottawa, ON K1N 6N5, Canada
[3] Hlth Canada, Off Sci, Therapeut Prod Directoriate, Ottawa, ON K1A 0L2, Canada
[4] Univ Ottawa, Dept Psychol, Ottawa, ON, Canada
[5] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada
关键词
skullcap; anxiety; cytochrome P450 3A4; baicalin; baicalein; gamma-aminobutyric acid;
D O I
10.1078/0944-7113-00374
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The phytochemistry and biological activity of Scutellaria lateriflora L. (American skullcap) which has been traditionally used as a sedative and to treat various nervous disorders such as anxiety was studied. In vivo animal behaviour trials were performed to test anxiolytic effects in rats orally administered S. laterifolia extracts. Significant increases in the number of entries into the center of an "open-field arena"; number of unprotected head dips, number of entries and the length of time spent on the open arms of the Elevated Plus-Maze were found. The identification and quantification of the flavonoid, baicalin in a 50% EtOH extract (40 mg/g) and its aglycone baicalein in a 95% EtOH extract (33 mg/g), as well as the amino acids GABA in H2O and EtOH extracts (similar to1.6 mg/g) and glutamine in a H2O extract (31 mg/g), was performed using HPLC. These compounds may play a role in anxiolytic activity since baicalin and baicalein are known to bind to the benzodiazepine site of the GABA(A) receptor and since GABA is the main inhibitory neurotransmitter.
引用
收藏
页码:640 / 649
页数:10
相关论文
共 19 条
  • [1] [Anonymous], 2000, HERBAL MED EXPANDED
  • [2] Brevoort P., 1998, HerbalGram, P33
  • [3] An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures
    Budzinski, JW
    Foster, BC
    Vandenhoek, S
    Arnason, JT
    [J]. PHYTOMEDICINE, 2000, 7 (04) : 273 - 282
  • [4] FILE SE, 1980, CURRENT PROTOCOLS NE
  • [5] FOSTER S, 1996, BUSINESS HERBS MAY, P14
  • [6] GAFNER S, 2000, INT C 48 ANN M SOC M
  • [7] Hirotani Masao, 1998, Natural Medicines, V52, P440
  • [8] Hui KM, 2000, PLANTA MED, V66, P91
  • [9] KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8
  • [10] KUBO M, 1985, CHEM PHARM BULL, V33, P2411